Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

NCT ID: NCT05987241

The MODERN study is a clinical trial designed to explore how a blood test can help identify bladder cancer patients who may need additional treatment after having their bladder surgically removed. ...

Recruiting

Phase: PHASE2 Conditions: Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7 +5 more

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

NCT ID: NCT06120491

This clinical trial is investigating a new treatment called Saruparib (AZD5305) for men with metastatic castration-sensitive prostate cancer, which means their cancer has spread but still responds ...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castration-Sensitive Prostate Cancer

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

NCT ID: NCT05812807

This clinical trial is studying whether the immunotherapy drug pembrolizumab is more effective than simply observing patients after surgery for early-stage triple-negative breast cancer. The trial ...

Recruiting

Phase: PHASE3 Conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 +2 more

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

NCT ID: NCT06096844

The ACHIEVE Trial is a clinical study designed to find out if combining chemotherapy with an immunotherapy drug called pembrolizumab is more effective than using immunotherapy alone for older adult...

Recruiting

Phase: PHASE3 Conditions: Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 +2 more

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT ID: NCT04389632

This clinical trial is studying a new drug called sigvotatug vedotin (SGN-B6A) to see how safe it is and if it can help treat various advanced solid tumors, such as lung cancer, breast cancer, and ...

Recruiting

Phase: PHASE1 Conditions: Ovarian Neoplasms, Esophageal Squamous Cell Carcinoma +10 more

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

NCT ID: NCT05939414

This clinical trial is studying a new treatment called lutetium (177Lu) vipivotide tetraxetan for men with oligometastatic prostate cancer (OMPC), which means their cancer has spread to a few place...

Recruiting

Phase: PHASE3 Conditions: Oligometastatic Prostate Cancer (OMPC)

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

NCT ID: NCT05538897

This clinical trial is studying a new treatment approach for women with recurrent or metastatic endometrial cancer, which is a type of cancer that starts in the lining of the uterus. The trial is t...

Recruiting

Phase: PHASE1 Conditions: Recurrent Endometrial Endometrioid Adenocarcinoma, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma +2 more

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

NCT ID: NCT05702034

The LIBREXIA-STROKE trial is studying a new medication called milvexian to see if it can help prevent another ischemic stroke in people who have recently experienced one or a high-risk transient is...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke; Ischemic Attack, Transient

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT ID: NCT06389136

This clinical trial is studying a medication called upadacitinib for adults with moderate to severe atopic dermatitis (AD), a skin condition that causes rashes and itching. The trial aims to find o...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NCT ID: NCT06548360

This clinical trial is studying a new cream called ruxolitinib to see if it is safe and effective for children with nonsegmental vitiligo, a condition where patches of skin lose their color. The tr...

Recruiting

Phase: PHASE3 Conditions: NonSegmental Vitiligo

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

NCT ID: NCT05952557

The CAMBRIA-2 trial is researching a new treatment called camizestrant for people with early-stage breast cancer that is hormone receptor-positive (ER+) and does not have a certain protein called H...

Recruiting

Phase: PHASE3 Conditions: Breast Cancer, Early Breast Cancer

Dental-Child Interaction Training

NCT ID: NCT06138405

This clinical trial, called Dental-Child Interaction Training, is focused on improving the way dental providers, like dentists and dental hygienists, interact with young children and their parents ...

Not yet recruiting

Phase: NA Conditions: Child Behavior, Behavior and Behavior Mechanisms

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castration-Resistant Prostate Cancer

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

NCT ID: NCT06638307

This clinical trial is testing a new treatment called MEN2312 for adults with advanced breast cancer, which means the cancer has spread and cannot be cured. MEN2312 is a type of medication that tar...

Recruiting

Phase: PHASE1 Conditions: Advanced Breast Cancer

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

NCT ID: NCT06358651

The PALISADE-3 clinical trial is studying a new treatment called Fasedienol Nasal Spray for adults aged 18 to 65 who struggle with Social Anxiety Disorder (SAD), particularly in situations like pub...

Recruiting

Phase: PHASE3 Conditions: Social Anxiety Disorder

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

NCT ID: NCT06760637

This clinical trial is studying a new treatment called PF-07220060, given alongside letrozole, for adults with a specific type of breast cancer known as HR-positive HER2-negative breast cancer. Thi...

Recruiting

Phase: PHASE3 Conditions: Breast Cancer

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

NCT ID: NCT06736041

This clinical trial is studying a new vaccine called PCV21, which aims to help protect babies from infections caused by a type of bacteria known as Streptococcus pneumoniae. The researchers want to...

Recruiting

Phase: PHASE3 Conditions: Pneumococcal Immunization

Exploring the Feasibility of Centering Pregnancy With Care Navigation

NCT ID: NCT05645549

This clinical trial is studying a program called Centering Pregnancy, which groups expectant mothers together for prenatal care, and adds support to help them navigate their healthcare. This progra...

Recruiting

Phase: NA Conditions: Premature Birth

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

NCT ID: NCT05538130

This clinical trial is studying a new medicine called PF-07799544 to see how safe and effective it is for people with advanced solid tumors, such as melanoma, brain cancer, thyroid cancer, and lung...

Recruiting

Phase: PHASE1 Conditions: Colorectal Cancer, Melanoma +5 more

Main Menu

Clinical Trials in Fayetteville, Arkansas

73 Active Trials Found in Fayetteville

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Dental-Child Interaction Training

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Exploring the Feasibility of Centering Pregnancy With Care Navigation

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors